A Medical Device Daily
Camstar Systems (Charlotte, North Carolina) a provider of manufacturing and quality software solutions for the Life Sciences, Solar and High Tech industries, reported that it has acquired Technology Resources Group (Singapore).
The company said that Technology Resources Group offers expertise in manufacturing execution equipment automation, manufacturing applications development and program management for enterprise solution deployments.
Camstar's acquisition of Technology Resources Group strengthens its leadership position in the Semiconductor, Solar and Electronics markets by expanding its services and support team in the Asia Pacific region. The move is expected to accelerate the growth of Camstar's comprehensive Manufacturing and Quality Platform in the region, where multinational, Chinese and Southeast Asian manufacturers alike focus on driving sustained growth while delivering to the quality standards that are expected by the global marketplace.
"Technology Resources Group is a longstanding and trusted partner, and their unwavering commitment to customer service and success mirrors our own," said Scott Toney, Camstar president/CEO. "This acquisition is a key part of Camstar's strategy for dominating the manufacturing execution and quality management markets in Asia, which continues to grow as the production destination for global manufacturers. Also, we will be well positioned to serve the Medical Device and Biotech industries as they expand manufacturing operations into Asia, ensuring product quality which is so critical to the Life Science sector."
In other dealmaking activity:
• SkinMedica (San Diego) and New York University (NYU; New York) reported that they have entered into a global license agreement to develop novel products to address skin hyperpigmentation based on technology invented at NYU.
"Our scientific discovery involves natural products that act by an entirely novel mechanism to modulate skin pigmentation," said Seth Orlow, MD, PhD, Chair of the Ronald Perelman Department of Dermatology at NYU, and Director of the Program in Cutaneous Biology and NYU Langone Medical Center's Center of Excellence in Cancers of the Skin. "The treatment of hyperpigmentation remains a major unmet need, and we are especially pleased to partner with SkinMedica to advance new products to address this problem."
Under the terms of the agreement, SkinMedica has licensed exclusive rights to develop and market products based on the NYU technology, with a range of applications in the modulation of skin pigmentation.
• Healthcare Trust of America (Scottsdale, Arizona) a self-managed non-traded real estate investment trust, reported the execution of a Purchase and Sale Agreement to acquire a 17-building portfolio located in Northwest Phoenix, Arizona for nearly $107 million.
The portfolio is located within the Sun City and Sun City West communities and on or near the campus of two significant Banner Health hospitals (Banner Boswell and Banner Del E. Webb). These hospitals are the dominant providers of healthcare services in these communities. Nearly 95% of the portfolio's square footage is located on or adjacent to one of these two hospital campuses.
The agreement contains a number of terms and conditions and anticipates a closing within 40 to 50 days.